» Articles » PMID: 34948402

NMR Hydrophilic Metabolomic Analysis of Bacterial Resistance Pathways Using Multivalent Antimicrobials with Challenged and Unchallenged Wild Type and Mutated Gram-Positive Bacteria

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Dec 24
PMID 34948402
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Multivalent membrane disruptors are a relatively new antimicrobial scaffold that are difficult for bacteria to develop resistance to and can act on both Gram-positive and Gram-negative bacteria. Proton Nuclear Magnetic Resonance (H NMR) metabolomics is an important method for studying resistance development in bacteria, since this is both a quantitative and qualitative method to study and identify phenotypes by changes in metabolic pathways. In this project, the metabolic differences between wild type ( samples and that was mutated through 33 growth cycles in a nonlethal dose of a multivalent antimicrobial agent were identified. For additional comparison, samples for analysis of the wild type and mutated strains of were prepared in both challenged and unchallenged conditions. A C-DABCO (1,4-diazabicyclo-2,2,2-octane) and mannose functionalized poly(amidoamine) dendrimer (DABCOMD) were used as the multivalent quaternary ammonium antimicrobial for this hydrophilic metabolic analysis. Overall, the study reported here indicates that likely change their peptidoglycan layer to protect themselves from the highly positively charged DABCOMD. This membrane fortification most likely leads to the slow growth curve of the mutated, and especially the challenged mutant samples. The association of these sample types with metabolites associated with energy expenditure is attributed to the increased energy required for the membrane fortifications to occur as well as to the decreased diffusion of nutrients across the mutated membrane.

Citing Articles

Metabolomic Profiles of Multidrug-Resistant Typhimurium from Humans, Bovine, and Porcine Hosts.

Overton J, Linke L, Magnuson R, Broeckling C, Rao S Animals (Basel). 2022; 12(12).

PMID: 35739855 PMC: 9219436. DOI: 10.3390/ani12121518.


The Integration of Proteomics and Metabolomics Data Paving the Way for a Better Understanding of the Mechanisms Underlying Microbial Acquired Drug Resistance.

Fortuin S, Soares N Front Med (Lausanne). 2022; 9:849838.

PMID: 35602483 PMC: 9120609. DOI: 10.3389/fmed.2022.849838.

References
1.
Lu W, Pieters R . Carbohydrate-protein interactions and multivalency: implications for the inhibition of influenza A virus infections. Expert Opin Drug Discov. 2019; 14(4):387-395. DOI: 10.1080/17460441.2019.1573813. View

2.
Bottone E . Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010; 23(2):382-98. PMC: 2863360. DOI: 10.1128/CMR.00073-09. View

3.
Perlin M, Clark D, McKenzie C, Patel H, Jackson N, Kormanik C . Protection of Salmonella by ampicillin-resistant Escherichia coli in the presence of otherwise lethal drug concentrations. Proc Biol Sci. 2009; 276(1674):3759-68. PMC: 2817278. DOI: 10.1098/rspb.2009.0997. View

4.
Wronska N, Majoral J, Appelhans D, Bryszewska M, Lisowska K . Synergistic Effects of Anionic/Cationic Dendrimers and Levofloxacin on Antibacterial Activities. Molecules. 2019; 24(16). PMC: 6719981. DOI: 10.3390/molecules24162894. View

5.
Paleos C, Tsiourvas D, Sideratou Z, Tziveleka L . Drug delivery using multifunctional dendrimers and hyperbranched polymers. Expert Opin Drug Deliv. 2010; 7(12):1387-98. DOI: 10.1517/17425247.2010.534981. View